Self-Amplifying RNA Vaccine Candidates: Alternative Platforms for mRNA Vaccine Development
Schmidt C, Schnierle BS
Abstract
The present use of mRNA vaccines against COVID-19 has shown for the first time the potential of mRNA vaccines for infectious diseases. Here we will summarize the current knowledge about improved mRNA vaccines, i.e., the self-amplifying mRNA (saRNA) vaccines. This approach may enhance antigen expression by amplification of the antigen-encoding RNA. RNA design, RNA delivery, and the innate immune responses induced by RNA will be reviewed.
Abstract of "Self-Amplifying RNA Vaccine Candidates: Alternative Platforms for mRNA Vaccine Development" by Schmidt C, Schnierle BS, https://doi.org/10.3390/pathogens12010138, used under its Creative Commons Attribution license (CC-BY); markup removed, otherwise unmodified.
Record
- Archive ID
- doi:10.3390/pathogens12010138
- Published
- Jan 13, 2023
- Venue
- Pathogens (Basel, Switzerland)
- DOI
- 10.3390/pathogens12010138
- PubMed
- 36678486
- PMC
- PMC9863218
- License
- CC-BY
- Provenance
- europepmc